These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 24956178)
21. Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase. Coelho C; Foti A; Hartmann T; Santos-Silva T; Leimkühler S; Romão MJ Nat Chem Biol; 2015 Oct; 11(10):779-83. PubMed ID: 26322824 [TBL] [Abstract][Full Text] [Related]
22. [Advances in the study of aldehyde oxidases]. Mi JQ; Li Y Yao Xue Xue Bao; 2014 May; 49(5):582-9. PubMed ID: 25151725 [TBL] [Abstract][Full Text] [Related]
23. QSAR of aromatic substances: protein tyrosine kinase inhibitory activity of flavonoid analogues. Deeb O; Clare BW Chem Biol Drug Des; 2007 Nov; 70(5):437-49. PubMed ID: 17927721 [TBL] [Abstract][Full Text] [Related]
24. A novel ring oxidation of 4- or 5-substituted 2H-oxazole to corresponding 2-oxazolone catalyzed by cytosolic aldehyde oxidase. Arora VK; Philip T; Huang S; Shu YZ Drug Metab Dispos; 2012 Sep; 40(9):1668-76. PubMed ID: 22621803 [TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions. Takaoka N; Sanoh S; Okuda K; Kotake Y; Sugahara G; Yanagi A; Ishida Y; Tateno C; Tayama Y; Sugihara K; Kitamura S; Kurosaki M; Terao M; Garattini E; Ohta S Biochem Pharmacol; 2018 Aug; 154():28-38. PubMed ID: 29678521 [TBL] [Abstract][Full Text] [Related]
26. A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834. Sodhi JK; Wong S; Kirkpatrick DS; Liu L; Khojasteh SC; Hop CE; Barr JT; Jones JP; Halladay JS Drug Metab Dispos; 2015 Jun; 43(6):908-15. PubMed ID: 25845827 [TBL] [Abstract][Full Text] [Related]
27. Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey and human. Sahi J; Khan KK; Black CB Drug Metab Lett; 2008 Aug; 2(3):176-83. PubMed ID: 19356090 [TBL] [Abstract][Full Text] [Related]
28. 3D-QSAR (CoMFA and CoMSIA) and pharmacophore (GALAHAD) studies on the differential inhibition of aldose reductase by flavonoid compounds. Caballero J J Mol Graph Model; 2010 Nov; 29(3):363-71. PubMed ID: 20863730 [TBL] [Abstract][Full Text] [Related]
29. Study of aldehyde oxidase-catalyzed metabolic pathway of phenanthridine using MCR-ALS method. Sorouraddin MH; Amini K; Naseri A; Asgari D; Rashidi MR Bioprocess Biosyst Eng; 2011 Feb; 34(2):173-7. PubMed ID: 20700607 [TBL] [Abstract][Full Text] [Related]
30. Identification of flavonoids and flavonoid rhamnosides from Rhododendron mucronulatum for. albiflorum and their inhibitory activities against aldose reductase. Mok SY; Lee S Food Chem; 2013 Jan; 136(2):969-74. PubMed ID: 23122151 [TBL] [Abstract][Full Text] [Related]
31. Human liver aldehyde oxidase: inhibition by 239 drugs. Obach RS; Huynh P; Allen MC; Beedham C J Clin Pharmacol; 2004 Jan; 44(1):7-19. PubMed ID: 14681337 [TBL] [Abstract][Full Text] [Related]
32. Dietary Flavonoids as Xanthine Oxidase Inhibitors: Structure-Affinity and Structure-Activity Relationships. Lin S; Zhang G; Liao Y; Pan J; Gong D J Agric Food Chem; 2015 Sep; 63(35):7784-94. PubMed ID: 26285120 [TBL] [Abstract][Full Text] [Related]
33. Effect of commonly used organic solvents on aldehyde oxidase-mediated vanillin, phthalazine and methotrexate oxidation in human, rat and mouse liver subcellular fractions. Behera D; Pattem R; Gudi G Xenobiotica; 2014 Aug; 44(8):722-33. PubMed ID: 24533630 [TBL] [Abstract][Full Text] [Related]
34. Identification of curcumin derivatives as human glyoxalase I inhibitors: A combination of biological evaluation, molecular docking, 3D-QSAR and molecular dynamics simulation studies. Yuan M; Luo M; Song Y; Xu Q; Wang X; Cao Y; Bu X; Ren Y; Hu X Bioorg Med Chem; 2011 Feb; 19(3):1189-96. PubMed ID: 21237663 [TBL] [Abstract][Full Text] [Related]
35. Mechanism of inhibition of human secretory phospholipase A2 by flavonoids: rationale for lead design. Lättig J; Böhl M; Fischer P; Tischer S; Tietböhl C; Menschikowski M; Gutzeit HO; Metz P; Pisabarro MT J Comput Aided Mol Des; 2007 Aug; 21(8):473-83. PubMed ID: 17701137 [TBL] [Abstract][Full Text] [Related]
36. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors. Klecker RW; Cysyk RL; Collins JM Bioorg Med Chem; 2006 Jan; 14(1):62-6. PubMed ID: 16143537 [TBL] [Abstract][Full Text] [Related]
37. Revisiting Aldehyde Oxidase Mediated Metabolism in Drug-like Molecules: An Improved Computational Model. Zhao J; Cui R; Wang L; Chen Y; Fu Z; Ding X; Cui C; Yang T; Li X; Xu Y; Chen K; Luo X; Jiang H; Zheng M J Med Chem; 2020 Jun; 63(12):6523-6537. PubMed ID: 32191458 [TBL] [Abstract][Full Text] [Related]
38. Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase. Choughule KV; Joswig-Jones CA; Jones JP Biochem Pharmacol; 2015 Aug; 96(3):288-95. PubMed ID: 26032640 [TBL] [Abstract][Full Text] [Related]
39. Virtual and in vitro bioassay screening of phytochemical inhibitors from flavonoids and isoflavones against xanthine oxidase and cyclooxygenase-2 for gout treatment. Li Y; Frenz CM; Li Z; Chen M; Wang Y; Li F; Luo C; Sun J; bohlin L; Li Z; Yang H; Wang C Chem Biol Drug Des; 2013 Apr; 81(4):537-44. PubMed ID: 23534413 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of quercetin on matrix metalloproteinase 9 activity molecular mechanism and structure-activity relationship of the flavonoid-enzyme interaction. Saragusti AC; Ortega MG; Cabrera JL; Estrin DA; Marti MA; Chiabrando GA Eur J Pharmacol; 2010 Oct; 644(1-3):138-45. PubMed ID: 20619256 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]